SIGA Technologies, Inc.

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-36.2M $-39.7M $-39.5M $-265.5M $-17.2M $-14.1M $29.1M $-50.3M
Depreciation & Amortization $132.2K $174.3K $247.4K $351.6K $463.1K $419.4K $568.3K $625.3K
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $1.1M $775.5K $1.6M $2.4M $2.3M $1.8M $12.5M $1.5M
Net Cash from Operating Activities $-18.4M $-116.8M $11.1M $14.2M $58.4M $-20.2M $25.6M $-10.8M
Investing Activities
Capital Expenditures $100.1K $23.9K $109.0K $28.0K $857.3K $588.2K $237.0K $549.9K
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-100.1K $1.2M $3.9M $-3.5M $-857.3K $-1.9M $14.8M $-10.5M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $84.0K $0 $0 — — $0 $1.4M $0
Net Cash from Financing Activities $-585.6K $59.1M $-2.0M $-2.3M $1.7M $4.9M $2.6M $13.2M
Net Change in Cash $-19.1M $-56.5M $13.0M $8.4M $59.3M $-17.2M $42.9M $-8.2M
Free Cash Flow $-18.5M $-116.8M $11.0M $14.1M $57.6M $-20.8M $25.3M $-11.4M
← Newer Page 2 of 3 Older →